Showing results (171-180 of 300) with videos related to

Sort By:
Pageof 30
Journal of Cardiovascular Pharmacology|November 1, 1985
Effect of calcium channel blockers on adrenergic and nonadrenergic vascular responses in manF Pasanisi, H L Elliott, P A Meredith, et al.
British Journal of Clinical Pharmacology|July 1, 1988
Ketanserin concentration-effect relationships in individual hypertensive patientsR Donnelly, H L Elliott, P A Meredith, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertensionH L Elliott, K McLean, D J Sumner, et al.
Journal of Hypertension|December 1, 1990
Prediction of the antihypertensive response to enalaprilP A Meredith, R Donnelly, H L Elliott, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Insulin action is associated with endothelial function in hypertension and type 2 diabetesS J Cleland, J R Petrie, M Small, et al.
Clinical Pharmacology and Therapeutics|March 1, 1981
Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockersH L Elliott, K McLean, D J Sumner, et al.
British Journal of Clinical Pharmacology|May 1, 1982
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjectsH L Elliott, P A Meredith, D J Sumner, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1988
Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosinP A Meredith, H L Elliott, A W Kelman, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Alpha-adrenoceptor number and function in platelets from treated and untreated patients with essential hypertension and age- and sex-matched controlsC R Jones, H L Elliott, N Deighton, et al.
Pageof 30